Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rumi Kawabata

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Oncology|January 19, 2011
Hydroxyflutamide enhances cellular sensitivity to 5-fluorouracil by suppressing thymidylate synthase expression in bicalutamide-resistant human prostate cancer cellsRumi Kawabata, Shinji Oie, Toshinori Oka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 15, 2006
[DLST as a method for detecting TS-1-induced allergy]Rumi Kawabata, Masahiro Koida, Shohei Kanie, et al.
International Journal of Oncology|April 2, 2011
Up-regulation of insulin-like growth factor-binding protein 3 by 5-fluorouracil (5-FU) leads to the potent anti-proliferative effect of androgen deprivation therapy combined with 5-FU in human prostate cancer cell linesRumi Kawabata, Shinji Oie, Masayuki Takahashi, et al.
Cancer Science|October 5, 2019
Activity of TAS4464, a novel NEDD8 activating enzyme E1 inhibitor, against multiple myeloma via inactivation of nuclear factor κB pathwaysHiromi Muraoka, Chihoko Yoshimura, Rumi Kawabata, et al.
Cancer Science|April 6, 2020
Acquired resistance to trastuzumab/pertuzumab or to T-DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728Hiroki Irie, Rumi Kawabata, Yayoi Fujioka, et al.
Plos One|April 17, 2015
Dynamic modulation of thymidylate synthase gene expression and fluorouracil sensitivity in human colorectal cancer cellsKentaro Wakasa, Rumi Kawabata, Seiki Nakao, et al.
International Journal of Oncology|July 3, 2013
Substitution of anti-androgens and tegafur-uracil combination therapy for castration-resistant prostate cancer: results of a multi-center randomized phase II studyMasayuki Takahashi, Rumi Kawabata, Akira Kawano, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Oncology|January 19, 2011
Hydroxyflutamide enhances cellular sensitivity to 5-fluorouracil by suppressing thymidylate synthase expression in bicalutamide-resistant human prostate cancer cellsRumi Kawabata, Shinji Oie, Toshinori Oka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 15, 2006
[DLST as a method for detecting TS-1-induced allergy]Rumi Kawabata, Masahiro Koida, Shohei Kanie, et al.
International Journal of Oncology|April 2, 2011
Up-regulation of insulin-like growth factor-binding protein 3 by 5-fluorouracil (5-FU) leads to the potent anti-proliferative effect of androgen deprivation therapy combined with 5-FU in human prostate cancer cell linesRumi Kawabata, Shinji Oie, Masayuki Takahashi, et al.
Cancer Science|October 5, 2019
Activity of TAS4464, a novel NEDD8 activating enzyme E1 inhibitor, against multiple myeloma via inactivation of nuclear factor κB pathwaysHiromi Muraoka, Chihoko Yoshimura, Rumi Kawabata, et al.
Cancer Science|April 6, 2020
Acquired resistance to trastuzumab/pertuzumab or to T-DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728Hiroki Irie, Rumi Kawabata, Yayoi Fujioka, et al.
Plos One|April 17, 2015
Dynamic modulation of thymidylate synthase gene expression and fluorouracil sensitivity in human colorectal cancer cellsKentaro Wakasa, Rumi Kawabata, Seiki Nakao, et al.
International Journal of Oncology|July 3, 2013
Substitution of anti-androgens and tegafur-uracil combination therapy for castration-resistant prostate cancer: results of a multi-center randomized phase II studyMasayuki Takahashi, Rumi Kawabata, Akira Kawano, et al.
Pageof 1